• Embed Doc
  • Copy Link
  • Readcast
  • Collections
  • CommentGo Back
Download
 
7
EXECUTIVE SUMMARY
Pharmacotherapies indicated for alcohol, narcotic, and nicotine addictions accountfor a market estimated at US$2 billion which is forecast to increase 41% CAGR toUS$2.9 billion by 2012 based on the expanded uptake of current and late-stagedevelopment drugs and increasing global prevalence of alcohol, narcotic, andnicotine dependencies. The introduction of novel therapies for these addictiondisorders, in addition to new pharmacotherapies for methamphetamine,phencyclidine, and gambling dependencies, are also predicted to significantlyincrease the market by a further US$2 billion by 2020.With over 30 drug candidates in the pipeline for addictions, medical therapies forthese highly prevalent difficult-to-treat conditions are on course for dynamic change.Novel drugs with unique therapeutic approaches and long-acting reformulations tocombat physical and psychological dependencies will revolutionize addictionpharmacotherapy interventions over the next 7 years.In this report,
The World Market for Addiction Disorders, 2005-2012: NewHorizons in High-Profile Dependency Markets,
the reader will be introduced to aspecialty pharmaceutical market positioned for high-growth based on analysis ofmarketed and pipeline drugs, company activities, and addiction disorderdemographics. Furthermore, the briefing comments on strategic and commercialissues that may affect product positioning and revenue optimization of currentproducts. The report also discusses key products such as naltrexone reformulations,nicotine replacement therapies, and novel vaccine therapies that have the potentialto create new market sectors and become high-value products over the next decade.Therapy area forecasting and illustrative comparative sales data is also presented togain insight into leading products with sales estimates to 2012. Forecasting to 2020is also detailed to enable the reader to make key assumptions about future marketsand prospects, and utilize the data for proprietary predictive market modelling.
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...